Effect of opicapone on levodopa pharmacokinetics, catechol‐O‐methyltransferase activity and motor fluctuations in patients with Parkinson's disease
JF Rocha - European Journal of Neurology, 2015 - Wiley Online Library
Background and purpose Opicapone (OPC) is a novel third generation catechol‐O‐
methyltransferase (COMT) inhibitor that enhances levodopa availability. This study …
methyltransferase (COMT) inhibitor that enhances levodopa availability. This study …
[PDF][PDF] Effect of opicapone on levodopa pharmacokinetics, catechol-O-methyltransferase activity and motor fluctuations in patients with Parkinson's disease
JJ Ferreiraa, JF Rochab, A Falcaoc, A Santosb… - 2015 - academia.edu
Background and purpose: Opicapone (OPC) is a novel third generation catechol-O-
methyltransferase (COMT) inhibitor that enhances levodopa availability. This study …
methyltransferase (COMT) inhibitor that enhances levodopa availability. This study …
Effect of opicapone on levodopa pharmacokinetics, catechol-O-methyltransferase activity and motor fluctuations in patients with Parkinson's disease
JJ Ferreira, JF Rocha, A Falcão, A Santos, R Pinto… - 2015 - pubmed.ncbi.nlm.nih.gov
Background and purpose Opicapone (OPC) is a novel third generation catechol-O-
methyltransferase (COMT) inhibitor that enhances levodopa availability. This study …
methyltransferase (COMT) inhibitor that enhances levodopa availability. This study …
Effect of opicapone on levodopa pharmacokinetics, catechol-O-methyltransferase activity and motor fluctuations in patients with Parkinson's disease.
JJ Ferreira, JF Rocha, A Falcão, A Santos… - European Journal of …, 2015 - europepmc.org
Background and purpose Opicapone (OPC) is a novel third generation catechol-O-
methyltransferase (COMT) inhibitor that enhances levodopa availability. This study …
methyltransferase (COMT) inhibitor that enhances levodopa availability. This study …
Effect of opicapone on levodopa pharmacokinetics, catechol‐O‐methyltransferase activity and motor fluctuations in patients with Parkinson's disease
JJ Ferreira, JF Rocha, A Falcão, A Santos… - European Journal of …, 2015 - infona.pl
Background and purpose Opicapone (OPC) is a novel third generation catechol‐O‐
methyltransferase (COMT) inhibitor that enhances levodopa availability. This study …
methyltransferase (COMT) inhibitor that enhances levodopa availability. This study …
[PDF][PDF] Effect of opicapone on levodopa pharmacokinetics, catechol-O-methyltransferase activity and motor fluctuations in patients with Parkinson's disease
JJ Ferreiraa, JF Rochab, A Falcaoc, A Santosb… - Neurology, 2015 - academia.edu
Background and purpose: Opicapone (OPC) is a novel third generation catechol-O-
methyltransferase (COMT) inhibitor that enhances levodopa availability. This study …
methyltransferase (COMT) inhibitor that enhances levodopa availability. This study …